Low-density lipoprotein cholesterol in oldest old with acute myocardial infarction: Is lower the better?

Hui-Hui Liu1, Meng Zhang1, Run-Zhen Chen1

  • 1Cardiometabolic Center, State Key Laboratory of Cardiovascular Disease, FuWai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 BeiLiShi Road, XiCheng District, Beijing 100037, China.

Age and Ageing
|September 11, 2022
PubMed

Insights

Low LDL-C levels (<1.8 mmol/l) are linked to higher cardiovascular mortality in elderly patients with acute myocardial infarction, particularly when combined with high hsCRP. This finding warrants further investigation in randomized controlled trials.

Area of Science:

  • Cardiology
  • Geriatrics
  • Biochemistry

Background:

  • The association between low-density lipoprotein cholesterol (LDL-C) and adverse outcomes in older adults is debated.
  • Understanding this relationship is crucial for managing cardiovascular risk in the elderly population.

Purpose of the Study:

  • To investigate the link between admission LDL-C levels and cardiovascular mortality (CVM) in individuals aged 80 years and above diagnosed with acute myocardial infarction (AMI).
  • To explore the combined effect of LDL-C and high-sensitivity C-reactive protein (hsCRP) on CVM in this demographic.

Main Methods:

  • A prospective, two-center cohort study involving 1,224 oldest old individuals with AMI.
  • Participants were stratified by baseline LDL-C (<1.8, 1.8–2.6, ≥2.6 mmol/l) and hsCRP (<10, ≥10 mg/l) levels.
  • Cardiovascular mortality was analyzed using Kaplan-Meier and multivariate Cox regression models.

Main Results:

  • Individuals with LDL-C <1.8 mmol/l exhibited the highest CVM.
  • A significantly lower risk of CVM was observed in patients with LDL-C ≥2.6 mmol/l compared to those with LDL-C <1.8 mmol/l (HR: 0.67, 95% CI: 0.46–0.98).
  • The highest CVM was found in patients with low LDL-C and high hsCRP levels.

Conclusions:

  • Low LDL-C (<1.8 mmol/l) is associated with increased CVM post-AMI in the oldest old, especially when hsCRP levels are high.
  • These findings suggest a potential paradox in lipid management for elderly AMI patients and highlight the importance of hsCRP.
  • Further validation through randomized controlled trials is recommended.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
17
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
271
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
837